Showing 25 - 27 of 27 results
Previous| 1 | 2 | 3 |Next
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.
Next Generation Armored Car T-Cell Therapy Trial Now Open
Clinical Trial Takes Aim at Promising Target in Advanced Gastric, Pancreatic Cancers
BROADCASTMED